Potential Coverage of the 4CMenB Vaccine against Invasive Serogroup B Neisseria meningitidis Isolated from 2009 to 2013 in the Republic of Ireland

Neisseria meningitidis is a common cause of bacterial meningitis in children and young adults worldwide. The 4CMenB vaccine (Bexsero), developed to combat meningococcal serogroup B (MenB) disease, contains subcapsular antigens that may induce immunity against strains of N. meningitidis, regardless o...

Descripción completa

Detalles Bibliográficos
Autores principales: Mulhall, Robert M., Bennett, Desiree, Cunney, Robert, Borrow, Ray, Lucidarme, Jay, Findlow, Jamie, Jolley, Keith A., Bray, James, Maiden, Martin C. J., Moschioni, Monica, Serino, Laura, Stella, Maria, Medini, Duccio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society for Microbiology 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6106058/
https://www.ncbi.nlm.nih.gov/pubmed/30135218
http://dx.doi.org/10.1128/mSphere.00196-18

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6106058/
https://www.ncbi.nlm.nih.gov/pubmed/30135218
http://dx.doi.org/10.1128/mSphere.00196-18

Ejemplares similares